BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17680617)

  • 61. The paramount importance of repeated left ventricular endomyocardial biopsy during the diagnosis of restrictive cardiomyopathy due to AL cardiac amyloidosis.
    Rubiś P; Rudnicka-Sosin L; Jurczyszyn A; Janion M; Podolec P
    Kardiol Pol; 2016; 74(8):796. PubMed ID: 27553348
    [No Abstract]   [Full Text] [Related]  

  • 62. Restrictive cardiomyopathy versus constrictive pericarditis: role of endomyocardial biopsy in avoiding unnecessary thoracotomy.
    Schoenfeld MH; Supple EW; Dec GW; Fallon JT; Palacios IF
    Circulation; 1987 May; 75(5):1012-7. PubMed ID: 3568302
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis.
    Berk JL; Keane J; Seldin DC; Sanchorawala V; Koyama J; Dember LM; Falk RH
    Chest; 2003 Sep; 124(3):969-77. PubMed ID: 12970025
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reversible restrictive cardiomyopathy due to light-chain deposition disease.
    Nakamura M; Satoh M; Kowada S; Satoh H; Tashiro A; Sato F; Masuda T; Hiramori K
    Mayo Clin Proc; 2002 Feb; 77(2):193-6. PubMed ID: 11838655
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Constrictive pericarditis and restrictive myocardiopathy].
    Espínola Zavaleta N; Maribel Vogel L; Isaac Tazar J; Yánac Chávez P; Romero Cárdenas A; Vargas Barrón J
    Arch Inst Cardiol Mex; 1999; 69(3):258-64. PubMed ID: 10529860
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cardiac involvements in hypereosinophilia-associated syndrome: Case reports and a little review of the literature.
    Jin X; Ma C; Liu S; Guan Z; Wang Y; Yang J
    Echocardiography; 2017 Aug; 34(8):1242-1246. PubMed ID: 28573678
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Contribution of magnetic resonance imaging to the diagnosis of 2 cases of cardiomyopathy].
    Zerbo F; Fiore D; Bressan M; Dalla Volta S
    Cardiologia; 1994 Oct; 39(10):737-40. PubMed ID: 7882396
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Amyloidosis and the heart: a comprehensive review.
    Shah KB; Inoue Y; Mehra MR
    Arch Intern Med; 2006 Sep; 166(17):1805-13. PubMed ID: 17000935
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management.
    Hassan W; Al-Sergani H; Mourad W; Tabbaa R
    Tex Heart Inst J; 2005; 32(2):178-84. PubMed ID: 16107109
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of usefulness of tissue Doppler imaging versus brain natriuretic peptide for differentiation of constrictive pericardial disease from restrictive cardiomyopathy.
    Sengupta PP; Krishnamoorthy VK; Abhayaratna WP; Korinek J; Belohlavek M; Sundt TM; Chandrasekaran K; Seward JB; Tajik AJ; Khandheria BK
    Am J Cardiol; 2008 Aug; 102(3):357-62. PubMed ID: 18638602
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sudden death possibly related to lenalidomide given for cardiac and muscle AL amyloidosis secondary to light chain deposition disease.
    Finsterer J; Höftberger R; Stöllberger C; Wöhrer A; Regele H
    J Oncol Pharm Pract; 2013 Jun; 19(2):170-4. PubMed ID: 22504167
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Novel Phenotype-Genotype Correlations of Restrictive Cardiomyopathy With Myosin-Binding Protein C (MYBPC3) Gene Mutations Tested by Next-Generation Sequencing.
    Wu W; Lu CX; Wang YN; Liu F; Chen W; Liu YT; Han YC; Cao J; Zhang SY; Zhang X
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26163040
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
    Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Restrictive cardiomyopathy.
    Zangwill S; Hamilton R
    Pacing Clin Electrophysiol; 2009 Jul; 32 Suppl 2():S41-3. PubMed ID: 19602161
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical spectrum of restrictive cardiomyopathy in children.
    Chen SC; Balfour IC; Jureidini S
    J Heart Lung Transplant; 2001 Jan; 20(1):90-2. PubMed ID: 11166616
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The restrictive cardiomyopathies.
    Child JS; Perloff JK
    Cardiol Clin; 1988 May; 6(2):289-316. PubMed ID: 3066485
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Myocardiopathies (XI). Restrictive myocardiopathy: concept, classification, and clinical approach].
    Huelmos A; Barba J; Martínez-Caro D
    Rev Esp Cardiol; 1996 Jul; 49(7):523-31. PubMed ID: 8754447
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Restrictive cardiomyopathy].
    Sadakari N; Kawai S; Okada R
    Nihon Rinsho; 1991 Jan; 49(1):56-63. PubMed ID: 2002611
    [No Abstract]   [Full Text] [Related]  

  • 79. [Amyloid cardiomyopathy: a link between cardiology and hematology. A case report of positive response to standard therapy].
    Petrillo G; Catalano L; Petruzziello F; Padula S; Petrillo C; Caso P
    G Ital Cardiol (Rome); 2007 Jun; 8(6):371-6. PubMed ID: 17633911
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Clinico-pathological evaluation of restrictive cardiomyopathy].
    TIAN Z; ZENG Y; FANG Q; ZHAO DC; CUI QC; CHENG KA; FANG LG; GAO P; CHENG ZW; JIANG XC; SUN RL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):786-9. PubMed ID: 21092644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.